News

13 September 2018

NeuroVocalix platform ready for clinical trials

NeuroVocalix enables novel voice-based cognitive assessments to be delivered directly to patients through mobile and tele-health platforms, helping to improve outcomes in clinical trials, aid clinical decision-making and play an important role in the management of long-term conditions such as chronic pain.

Read on

1 August 2018

Healthy Amplified launch new population health platform with CANTAB technology

Healthy Amplified are using CANTAB^® technology to expand their population health platform offering to adults. 

Read on

28 June 2018

CANTAB technology selected for world’s largest dementia study

We are pleased to announce our partnership with Dementias Platform UK (DPUK), the world’s largest study group in dementia research formed to accelerate the development of effective, and ultimately preventative, treatments for diseases such as Alzheimer’s.

Read on

20 June 2018

New product to improve workplace mental health

We are very pleased to announce a planned new software product to assess mental health and wellbeing at work, CANTAB BrainHealth™.

Read on

7 June 2018

Cambridge Cognition and University of Bristol in partnership to tackle growing mental health need

Mental and substance use disorders are now the leading cause of disability worldwide, resulting in 23% of all years lost with a global economic loss of a trillion US dollars every year¹ which is why we are very pleased to announce a new strategic collaboration and partnership with the University of Bristol to accelerate the development of novel brain health products.

Read on

31 May 2018

New client signs with Cognition Kit software

We’re delighted to announce a new $0.5m contract with a major pharmaceutical company for the use of our Cognition Kit digital health software in a clinical trial.

Read on